DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

DexCom is expected to announce its second-quarter earnings soon, and Wall Street expects the company’s EPS to increase by a ...

DexCom DXCM recently announced that it will begin rolling out its fully reimagined Stelo app experience in the United States ...

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue ...

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...

Compare the best Samsung Watch CGM apps and Wear OS tools for blood sugar readings, including Dexcom G6, Gluroo, and xDrip+.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...

DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of the Dexcom G7 continuous glucose monitoring (CGM) system significantly ...

Mark Andrews may be one of the best tight ends in the NFL, but he has not forgotten about the kids playing college football today. The former Oklahoma Sooners standout is using his platform as an ...

The Padres' Jackson Merrill helped guide hundreds of young athletes through drills at the FlexWork baseball camp in La Jolla.

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in a ...

On a promising note, management expects CGM to return to double-digit growth in the second quarter. The Libre portfolio, Abbott’s flagship CGM franchise, is used by more than 8 million people across ...